1. Home
  2. FGEN vs NSYS Comparison

FGEN vs NSYS Comparison

Compare FGEN & NSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • NSYS
  • Stock Information
  • Founded
  • FGEN 1993
  • NSYS 1981
  • Country
  • FGEN United States
  • NSYS United States
  • Employees
  • FGEN N/A
  • NSYS N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • NSYS Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • NSYS Technology
  • Exchange
  • FGEN Nasdaq
  • NSYS Nasdaq
  • Market Cap
  • FGEN 33.5M
  • NSYS 22.7M
  • IPO Year
  • FGEN 2014
  • NSYS N/A
  • Fundamental
  • Price
  • FGEN $5.61
  • NSYS $8.79
  • Analyst Decision
  • FGEN Strong Buy
  • NSYS
  • Analyst Count
  • FGEN 1
  • NSYS 0
  • Target Price
  • FGEN $250.00
  • NSYS N/A
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • NSYS 37.9K
  • Earning Date
  • FGEN 08-05-2025
  • NSYS 08-07-2025
  • Dividend Yield
  • FGEN N/A
  • NSYS N/A
  • EPS Growth
  • FGEN N/A
  • NSYS N/A
  • EPS
  • FGEN N/A
  • NSYS N/A
  • Revenue
  • FGEN $6,996,000.00
  • NSYS $120,813,000.00
  • Revenue This Year
  • FGEN N/A
  • NSYS N/A
  • Revenue Next Year
  • FGEN N/A
  • NSYS N/A
  • P/E Ratio
  • FGEN N/A
  • NSYS N/A
  • Revenue Growth
  • FGEN N/A
  • NSYS N/A
  • 52 Week Low
  • FGEN $4.50
  • NSYS $7.25
  • 52 Week High
  • FGEN $38.25
  • NSYS $15.55
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 39.07
  • NSYS 48.78
  • Support Level
  • FGEN $4.85
  • NSYS $8.35
  • Resistance Level
  • FGEN $5.77
  • NSYS $9.50
  • Average True Range (ATR)
  • FGEN 0.57
  • NSYS 0.88
  • MACD
  • FGEN -0.02
  • NSYS 0.05
  • Stochastic Oscillator
  • FGEN 31.67
  • NSYS 36.69

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical, and manufacturing services and support, including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense, and Industrial markets, with key revenue coming from medical-related markets.

Share on Social Networks: